Telomere aggregates in trisomy 21 amniocytes

Cancer Genetics and Cytogenetics

Volumn 195, Issue 1, 2009, Pages 23-26

  Hadi, Efrat ^a   Sharony, Reuven ^a,b   Goldberg Bittman, Lilach ^a,c   Biron Shental, Tal ^a,b   Fejgin, Moshe ^a,b   Amiel, Aliza ^a,c  

^a MEIR MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c BAR ILAN UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

PEPTIDE NUCLEIC ACID;

ACUTE LEUKEMIA; AMNION CELL; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN SYNDROME; FEMALE; FLUORESCENCE MICROSCOPY; GENE FREQUENCY; GENETIC PREDISPOSITION; GENOMIC INSTABILITY; HUMAN; HUMAN CELL; PREGNANCY DISORDER; PRIORITY JOURNAL; RISK ASSESSMENT; TELOMERE;

AMNIOTIC FLUID; CASE-CONTROL STUDIES; CELLS, CULTURED; DIPLOIDY; DOWN SYNDROME; FEMALE; HUMANS; MICROSCOPY, FLUORESCENCE; PREGNANCY; TELOMERE;

EID: 70349886561     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2009.03.003     Document Type: Article

References (31)

1. Kajii T., Ferrier A., Niikawa N., Takahara H., Ohama K., and Avirachan S. Anatomic and chromosomal anomalies in 639 spontaneous abortuses. Hum Genet 55 (1980) 87-98
2. Snijders R.J., Sebire N.J., and Nicolaides K.H. Maternal age and gestational age-specific risk for chromosomal defects. Fetal Diagn Ther 10 (1995) 356-367
3. Hook E.B. Chromosome abnormalities: prevalence, risk, and recurrence. In: Brock D.J.H., Rodeck C.H., and Ferguson-Smith M.A. (Eds). Prenatal diagnosis and screening (1992), Churchill Livingstone, Edinburgh 351-392
4. Egan J.F., Benn P.A., Zelop C.M., Bolnick A., Gianferrari E., and Borgida A.F. Down syndrome births in the United States from 1989 to 2001. Am J Obstet Gynecol 191 (2004) 1044-1048
5. Antonarakis S.E., Lyle R., Dermitzakis E.T., Reymond A., and Deutsch S. Chromosome 21 and Down syndrome: from genomics to pathophysiology. Nat Rev Genet 5 (2004) 725-738
6. Shapiro B.L. Down syndrome: a disruption of homeostasis. Am J Med Genet 14 (1983) 241-269
7. Hernandez D., and Fisher E.M. Down syndrome genetics: unravelling a multifactorial disorder. Hum Mol Genet (1996) 5 Spec No:1411-6
8. Duesberg P., Fabarius A., and Hehlmann R. Aneuploidy, the primary cause of the multilateral genomic instability of neoplastic and preneoplastic cells. IUBMB Life 56 (2004) 65-81
9. Dynek J.N., and Smith S. Resolution of sister telomere association is required for progression through mitosis. Science 304 (2004) 97-100
10. Pathak S., and Multani A.S. Aneuploidy, stem cells and cancer. EXS 96 (2006) 49-64
11. Chuang T.C.Y., Moshir S., Garini Y., Chuang A.Y., Young I.T., Vermolen B., van den Doel R., Mougey V., Perrin M., Braun M., Kerr P.D., Fest T., Boukamp P., and Mai S. The three-dimensional organization of telomeres in the nucleus of mammalian cells. BMC Biol 2 (2004) 12
12. Louis S.F., Vermolen B.J., Garini Y., Young I.T., Guffei A., Lichtensztejn Z., Kuttler F., Chuang T.C., Moshir S., Mougey V., Chuang A.Y., Kerr P.D., Fest T., Boukamp P., and Mai S. c-Myc induces chromosomal rearrangements through telomere and chromosome remodeling in the interphase nucleus. Proc Natl Acad Sci U S A 102 (2005) 9613-9618
13. DePinho R.A., and Polyak K. Cancer chromosomes in crisis. Nat Genet 36 (2004) 932-934
14. Artandi S.E., Chang S., Lee S.L., Alson S., Gottlieb G.J., Chin L., and DePinho R.A. Telomere dysfunction promotes non-reciprocal translocations and epithelial cancers in mice. Nature 406 (2000) 641-645
15. Murnane J.P., and Sabatier L. Chromosome rearrangements resulting from telomere dysfunction and their role in cancer. Bioessays 26 (2004) 1164-1174
16. Goldberg-Bittman L., Kitay-Cohen Y., Quitt M., Hadary R., Fejgin M.D., Yukla M., and Amiel A. Telomere aggregates in non-Hodgkin lymphoma (NHL) patients at different disease stages. Cancer Genet Cytogenet 184 (2008) 105-108
17. Amiel A., Fejgin M.D., Goldberg-Bittman L., Sharoni R., Hadary R., and Kitay-Cohen Y. Telomere aggregates in hepatitis C patients. Cancer Invest 27 (2009) 650-654
18. Mai S., and Garini Y. The significance of telomeric aggregates in the interphase nuclei of tumor cells. J Cell Biochem 97 (2006) 904-915
19. Vaziri H., Schächter F., Uchida I., Wei L., Zhu X., Effros R., Cohen D., and Harley C.B. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am J Hum Genet 52 (1993) 661-667
20. Jenkins E.C., Velinov M.T., Ye L., Gu H., Li S., Jenkins Jr. E.C., Brooks S.S., Pang D., Devenny D.A., Zigman W.B., Schupf N., and Silverman W.P. Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementia. Neurobiol Aging 27 (2006) 941-945
21. Jenkins E.C., Ye L., Gu H., Ni S.A., Duncan C.J., Velinov M., Pang D., Krinsky-McHale S.J., Zigman W.B., Schupf N., and Silverman W.P. Increased "absence" of telomeres may indicate Alzheimer's disease/dementia status in older individuals with Down syndrome. Neurosci Lett 440 (2008) 340-343
22. Dixon N., Kishnani P.S., and Zimmerman S. Clinical manifestations of hematologic and oncologic disorders in patients with Down syndrome. Am J Med Genet C Semin Med Genet 142C (2006) 149-157
23. Patja K., Pukkala E., Sund R., Iivanainen M., and Kaski M. Cancer incidence of persons with Down syndrome in Finland: a population-based study. Int J Cancer 118 (2006) 1769-1772
24. Hill D.A., Gridley G., Cnattingius S., Mellemkjaer L., Linet M., Adami H.O., Olsen J.H., Nyren O., and Fraumeni Jr. J.F. Mortality and cancer incidence among individuals with Down syndrome. Arch Intern Med 163 (2003) 705-711
25. Forestier E., Izraeli S., Beverloo B., Haas O., Pession A., Michalová K., Stark B., Harrison C.J., Teigler-Schlegel A., and Johansson B. Cytogenetic features of acute lymphoblastic and myeloid leukemias in pediatric patients with Down syndrome: an iBFM-SG study. Blood 111 (2008) 1575-1583
26. Birchler J.A., Riddle N.C., Auger D.L., and Veitia R.A. Dosage balance in gene regulation: biological implications. Trends Genet 21 (2005) 219-226
27. Amiel A., Korenstein A., Gaber E., and Avivi L. Asynchronous replication of alleles in genomes carrying an extra autosome. Eur J Hum Genet 7 (1999) 223-230
28. Amiel A., Leopold L., Gronich N., Yukla M., Fejgin M.D., and Lishner M. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia patients. Cancer Genet Cytogenet 167 (2006) 145-149
29. Amiel A., Goldzak G., Gaber E., Yosef G., Fejgin M.D., Yukla M., and Lishner M. Random aneuploidy and telomere capture in chronic lymphocytic leukemia and chronic myeloid leukemia patients. Cancer Genet Cytogenet 163 (2005) 12-16
30. Birchler J.A., and Newton K.J. Modulation of protein levels in chromosomal dosage series of maize: the biochemical basis of aneuploid syndromes. Genetics 99 (1981) 247-266
31. Birchler J.A., Bhadra U., Bhadra M.P., and Auger D.L. Dosage-dependent gene regulation in multicellular eukaryotes: implications for dosage compensation, aneuploid syndromes, and quantitative traits. Dev Biol 234 (2001) 275-288